Arizona State Retirement System purchased a new position in shares of INC Research Holdings, Inc. (NASDAQ:INCR) during the second quarter, according to its most recent disclosure with the SEC. The fund purchased 22,830 shares of the company’s stock, valued at approximately $1,336,000.

Several other hedge funds have also recently made changes to their positions in INCR. Palisade Capital Management LLC NJ raised its stake in shares of INC Research Holdings by 7.7% in the second quarter. Palisade Capital Management LLC NJ now owns 433,598 shares of the company’s stock worth $25,365,000 after buying an additional 31,151 shares during the last quarter. Retirement Systems of Alabama purchased a new stake in shares of INC Research Holdings during the second quarter worth about $5,964,000. Texas Permanent School Fund purchased a new stake in shares of INC Research Holdings during the second quarter worth about $2,311,000. Rothschild Asset Management Inc. raised its stake in shares of INC Research Holdings by 6.6% in the second quarter. Rothschild Asset Management Inc. now owns 491,151 shares of the company’s stock worth $28,732,000 after buying an additional 30,291 shares during the last quarter. Finally, Great West Life Assurance Co. Can raised its stake in shares of INC Research Holdings by 469.6% in the second quarter. Great West Life Assurance Co. Can now owns 32,325 shares of the company’s stock worth $1,889,000 after buying an additional 26,650 shares during the last quarter. Hedge funds and other institutional investors own 99.84% of the company’s stock.

Shares of INC Research Holdings, Inc. (NASDAQ:INCR) opened at 56.20 on Friday. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of 34.44 and a beta of 1.42. The firm’s 50-day moving average price is $56.26 and its 200-day moving average price is $52.19. INC Research Holdings, Inc. has a 12-month low of $40.65 and a 12-month high of $61.10.

INC Research Holdings (NASDAQ:INCR) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.64 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.64. The business had revenue of $258.10 million during the quarter, compared to analyst estimates of $256.76 million. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The business’s revenue was down .3% on a year-over-year basis. During the same period last year, the business earned $0.61 EPS. On average, analysts forecast that INC Research Holdings, Inc. will post $2.61 EPS for the current fiscal year.

WARNING: “Arizona State Retirement System Invests $1.34 Million in INC Research Holdings, Inc. (INCR)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/27/arizona-state-retirement-system-invests-1-34-million-in-inc-research-holdings-inc-incr.html.

A number of analysts have weighed in on the company. Goldman Sachs Group, Inc. (The) restated a “buy” rating and set a $65.00 target price on shares of INC Research Holdings in a report on Monday, August 7th. TheStreet lowered INC Research Holdings from a “b” rating to a “c” rating in a report on Friday, July 28th. Jefferies Group LLC restated a “hold” rating and set a $62.50 target price on shares of INC Research Holdings in a report on Sunday, July 30th. BidaskClub lowered INC Research Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, William Blair lowered INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 20th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $63.79.

In related news, CEO Alistair Macdonald sold 8,828 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $55.65, for a total transaction of $491,278.20. Following the completion of the sale, the chief executive officer now directly owns 110,629 shares of the company’s stock, valued at approximately $6,156,503.85. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Christopher L. Gaenzle sold 6,873 shares of the firm’s stock in a transaction on Friday, June 30th. The shares were sold at an average price of $58.32, for a total transaction of $400,833.36. Following the sale, the chief accounting officer now directly owns 47,450 shares of the company’s stock, valued at $2,767,284. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 26,256 shares of company stock valued at $1,508,312. Company insiders own 0.24% of the company’s stock.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Stock Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related stocks with our FREE daily email newsletter.